Wave Life Sciences (WVE) Common Equity (2016 - 2025)
Historic Common Equity for Wave Life Sciences (WVE) over the last 11 years, with Q3 2025 value amounting to $124.5 million.
- Wave Life Sciences' Common Equity fell 1206.65% to $124.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $124.5 million, marking a year-over-year decrease of 1206.65%. This contributed to the annual value of $209.5 million for FY2024, which is 42867.78% up from last year.
- According to the latest figures from Q3 2025, Wave Life Sciences' Common Equity is $124.5 million, which was down 1206.65% from $139.3 million recorded in Q2 2025.
- Wave Life Sciences' Common Equity's 5-year high stood at $209.5 million during Q4 2024, with a 5-year trough of -$51.7 million in Q2 2023.
- Moreover, its 5-year median value for Common Equity was $29.9 million (2021), whereas its average is $44.2 million.
- Its Common Equity has fluctuated over the past 5 years, first crashed by 6539811.32% in 2023, then soared by 410534.94% in 2025.
- Wave Life Sciences' Common Equity (Quarter) stood at $32.5 million in 2021, then plummeted by 238.75% to -$45.1 million in 2022, then soared by 187.89% to $39.6 million in 2023, then skyrocketed by 428.68% to $209.5 million in 2024, then tumbled by 40.55% to $124.5 million in 2025.
- Its Common Equity was $124.5 million in Q3 2025, compared to $139.3 million in Q2 2025 and $171.8 million in Q1 2025.